Lipid‐Lowering Therapy Use When Indicated and Subsequent Ischemic Stroke Severity
Background Elevated low‐density lipoprotein cholesterol is a risk factor for atherosclerotic cardiovascular disease, including acute ischemic stroke (AIS), due to large‐ and small‐vessel disease. Cholesterol management guidelines recommend lipid‐lowering therapy (LLT) to prevent atherosclerotic card...
Saved in:
| Main Authors: | Barbara Gordon‐Kundu, Reza Peyravi, Anisha Garg, Anna Baker, Samantha Salas, Michael Levien, Kamil F. Faridi, Adam de Havenon, Harlan M. Krumholz, Kevin N. Sheth, Rachel Forman, Richa Sharma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.123.033365 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hypolipidemic effectiveness and safety of generic lovastatin
by: D. M. Aronov, et al.
Published: (2006-12-01) -
Past, Present, and Future of Familial Hypercholesterolemia Management
by: Viviane Z. Rocha, et al.
Published: (2021-09-01) -
The treatment of cholesterol: issues, effects and targets
by: James A. Ker
Published: (2010-12-01) -
Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01) -
Cholesterol Atheroembolism Syndrome: Current State of the Problem
by: z. D. Mikhailova, et al.
Published: (2020-07-01)